| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/08/2004 | EP1453852A2 Selective urokinase inhibitors |
| 09/08/2004 | EP1453848A2 Sir2 products and activities |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453841A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them |
| 09/08/2004 | EP1453840A1 Phosphonates useful as modulators of t-gamma-9-delta-2 lymphocyte activity |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453827A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453812A2 Cytotoxic agents |
| 09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 09/08/2004 | EP1453803A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/08/2004 | EP1453800A2 Protein kinase inhibitors |
| 09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 09/08/2004 | EP1453787A1 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
| 09/08/2004 | EP1453783A1 Substituted aryl-cycloalkanes, and use thereof as anticancer agents |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453532A2 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453518A1 Pharmaceutical composition for the treatment of disorders of non-human mammals |
| 09/08/2004 | EP1453517A1 Platinum derivative pharmaceutical formulations |
| 09/08/2004 | EP1453513A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 09/08/2004 | EP1453510A2 Neurotransmitter balance chemotherapy |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
| 09/08/2004 | EP1453507A2 Solubilized topoisomerase poison agents |
| 09/08/2004 | EP1453503A2 Ep4 receptor agonist, compositions and methods thereof |
| 09/08/2004 | EP1453502A2 Pharmaceutical formulations comprising indolinone derivatives |
| 09/08/2004 | EP1453496A2 Composition and method for modulating bar/fxr receptor activity |
| 09/08/2004 | EP1453471A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1289950B1 Serine protease inhibitors |
| 09/08/2004 | EP1235850B1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/08/2004 | EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes |
| 09/08/2004 | EP1150746B1 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 09/08/2004 | EP1131087B1 Methods of alleviating cancer symptoms |
| 09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP1075281B1 Polyol-ifn-beta conjugates |
| 09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | EP0758232B1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
| 09/08/2004 | CN1527836A Antiviral agents for treatment of flaviviridae infections |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527726A Conjugates of erythropoietin (PEP) with polyethylene glycol (PEG) |
| 09/08/2004 | CN1527724A Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/08/2004 | CN1527721A Compositions comprising mixtures of human cytokines and methods of producing the same |
| 09/08/2004 | CN1527718A Method for short-term and long-term drug dosimetry |
| 09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 09/08/2004 | CN1527703A Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 09/08/2004 | CN1527698A 控释可生物降解的凝胶基质 Controlled release biodegradable gel matrix |
| 09/08/2004 | CN1526728A Human tumor generating and metastasis promoting acceptor molecule and its encoding gene and application |
| 09/08/2004 | CN1526727A Mouse tumor generating andmetastasis promoting acceptor and its encoding gene and application |
| 09/08/2004 | CN1526725A Antitumor polypeptide and its application |
| 09/08/2004 | CN1526722A New taraxerol derivative and its prepn and use |
| 09/08/2004 | CN1526718A Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
| 09/08/2004 | CN1526713A Combretastatin A-4 as phosphorylcholine precursor medicine and its synthesis and application |
| 09/08/2004 | CN1526450A Anticancer biological missile of internal radiating radium nuclein |
| 09/08/2004 | CN1526447A Human blood vessel IBP sample growth factor |
| 09/08/2004 | CN1526446A Recombinant phage vaccine of tumor proliferation related growth factor and its application |
| 09/08/2004 | CN1526407A Antitumor protopanoxadiol injection and its prepn process |
| 09/08/2004 | CN1526405A Antitumor ginsenoside Rg3 injection and its prepn process |
| 09/08/2004 | CN1526404A Antitumor ginsenoside C-K injection and its prepn process |
| 09/08/2004 | CN1526403A Antitumor ginsenoside Rh2 injection and its prepn process |
| 09/08/2004 | CN1526395A Tegafur-sodium chloride injection and its prepn |
| 09/08/2004 | CN1526388A New use of 3,7,3'4'-substituted flavone |
| 09/08/2004 | CN1526387A Taxol vesicle injection and its prepn |
| 09/08/2004 | CN1526378A Application of effective rhubarb component in preparing medicine for strengthening AS2O3 to induce programmed tumor cell death |
| 09/08/2004 | CN1165764C Anti PSMA antibody or antigen binding part, and their use |
| 09/08/2004 | CN1165618C Polynucleotide immunogenic agents |
| 09/08/2004 | CN1165617C Oligonucleotides for inhibiting expression of human eg5 |
| 09/08/2004 | CN1165545C Method for separating and extracting total flavone from goldenrain tree plant and its application |
| 09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165509C Gronwell naphthaquinone derivative and its application in preparing anticancer medicine |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165315C Remedies for joint diseases |
| 09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 09/08/2004 | CN1165301C Use of compositions for preparing anticancer medicines |
| 09/07/2004 | US6787672 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-one derivatives; antiproliferative and antiinflammatory agents |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787546 Heterocycle derivatives and drugs |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787539 2,4,5,-trisubstituted pyrimidine derivatives |
| 09/07/2004 | US6787538 Hormone replacement therapy; agonists, antagonists; antiestrogens with little to no intrinsic estrogenicity |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/07/2004 | US6787525 Method of treating hiv infections and/or cancer diseases |